ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2025
In vitro antimicrobial activity of polyhexamethylene guanidine hydrochloride and polyhexamethylene biguanide against microorganisms causing bovine mastitis.
Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Antibiotic-Free Strategies for Managing Antimicrobial-Resistant Infections.Pharmaceutics · 2026Review
- Surface Carrier Testing of Hospital Antiseptics AgainstPathogens (Basel, Switzerland) · 2026Article
- 3D-Printed PLDLA-TMC/PEG 400 Vascular Scaffolds with a Poly(hexamethylene Biguanide) Antibacterial Coating.Pharmaceutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bovine mastitis not only affects the health of cows but also causes economic losses and public health concerns due to the presence of zoonotic and resistant microorganisms in milk and its derivatives. Thus, the present study aimed to evaluate the in vitro antimicrobial activity of polyhexamethylene guanidine hydrochloride (PHMGH) and polyhexamethylene biguanide hydrochloride (PHMB) against standard and clinical isolated bacteria strains that causes clinical mastitis (Staphylococcus aureus ATCC 6538 and clinical isolate, Staphylococcus epidermidis ATCC 12228, Streptococcus agalactiae ATCC 12386, Streptococcus dysgalactiae ATCC 12238, and Escherichia coli ATCC 14948 and clinical isolate). The polymers were tested at concentrations ranging from 0.3 ppm to 5000 ppm and compared to the commercial product benzalkonium chloride (BKC). The minimum inhibitory concentration (MIC) technique determined the lowest concentration of polymers capable of inhibiting microbial growth, while the minimum bactericidal concentration (MBC) characterized the lowest concentration with bactericidal or bacteriostatic action. Fractional inhibitory concentration index (FICI) assessed the synergy of polymers with BKC. To determine the time required for microbial death in the presence of polymers and BKC, the bactericidal kinetics technique was employed, and the minimum inhibitory concentration for biofilm inhibition (CIMB75) assessed the lowest concentration of polymers inhibiting 75% or more of biofilm formation. The data indicated that both PHMGH and PHMB were effective against all tested microorganisms at concentrations ranging from 0.3 to 9.6 ppm, as determined by MIC and MBC. FICI showed indifferent effects of polymer combinations with BKC against most microorganisms, except for PHMGH against Staphylococcus aureus, which exhibited additive effects. Bactericidal kinetics demonstrated that polymers immediately reduced microbial load by more than 90% against tested microorganisms, unlike BKC. CIMB75 showed that polymers inhibited 75% of biofilm formation, with PHMGH proving more effective. Based on these results, synthetic polymers PHMGH and PHMB showed promising in vitro antimicrobial effects against pathogens causing bovine mastitis, suggesting potential for developing new preventive products for this mammary condition.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.